Takeda Pharmaceutical TAK
NYSE TAK
$18.48 -0.42 (-2.22%)
As of: Sep 29, 2026 · 3:59 PM EDT

Takeda Pharmaceutical (TAK) Current Debt (2020 - 2021)

Updated

Takeda Pharmaceutical's Current Debt was -$2.27 billion in the year ended Mar 31, 2026, compared with $180.47 million a year earlier.

Analysis

Takeda Pharmaceutical (TAK) Current Debt (2020 - 2021) Analysis & Trends

From the year ended Mar 31, 2017 onward, Takeda Pharmaceutical has reported Current Debt for 10 years.

  • The figure for the year ended Mar 31, 2026 marks the lowest annual Current Debt since the year ended Mar 31, 2020.
  • Per Business Quant data, Current Debt in earlier years was $180.47 million in the year ended Mar 31, 2025 (-90.6%), $1.92 billion in the year ended Mar 31, 2024 (+548.7%), $296.09 million in the year ended Mar 31, 2023 and -$17,814 in the year ended Mar 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 208.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 37.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 64.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Takeda Pharmaceutical 2.74 Bn -23.77 Bn 5.10 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 9,135.02
Jun 30, 2020 -92.98 Mn
API Access

Takeda Pharmaceutical Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=TAK&period=max&api_key=YOUR_API_KEY